Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-08-04

AUTHORS

Thomas Zeller, Aljoscha Rastan, Roland Macharzina, Ulrich Beschorner, Elias Noory

ABSTRACT

Introducing anti-restenotic drug-based treatment modalities in femoropopliteal interventions is the potential revolutionizing reperfusion treatment of peripheral artery disease. Durability of recanalization procedures using drug-coated balloons (DCB) and drug-eluting stents (DES) yields in excellent mid-term and long-term technical and clinical outcomes and may be cost saving on the long term as compared to traditional treatment modalities such as plain old balloon angioplasty (POBA) and bare metal nitinol stent implantation. Drug-eluting bioresorbable scaffolds are another drug-based promising treatment option but are still investigational. In particular, DCB provide a novel method to locally deliver paclitaxel into the arterial wall without the need of a chronically implanted delivery system or even if those devices will be indicated, they can be delivered focally. Following the first positive pilot studies, two large pivotal trials have confirmed superiority of DCB over plain old balloon angioplasty (POBA) in the treatment of TASC II A and B femoropopliteal lesions. Even for more complex femoropopliteal lesions such as long lesions and instent restenosis, single center studies and small randomized studies have shown promising mid-term technical and clinical results. For DES, follow-up data for the only commercially available device are now presented up to 5 years with excellent clinical outcome regarding freedom from target lesion revascularization and improvement of walking capacity. This review article summarizes the current knowledge and perspectives of drug-based endovascular treatment modalities in femoropopliteal interventions and discusses still unresolved needs. More... »

PAGES

69

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11886-015-0624-6

DOI

http://dx.doi.org/10.1007/s11886-015-0624-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016374178

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26238739


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Absorbable Implants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angioplasty, Balloon", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Flow Velocity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coated Materials, Biocompatible", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Femoral Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peripheral Arterial Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Popliteal Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Patency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.418466.9", 
          "name": [
            "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zeller", 
        "givenName": "Thomas", 
        "id": "sg:person.01306206724.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.418466.9", 
          "name": [
            "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rastan", 
        "givenName": "Aljoscha", 
        "id": "sg:person.0620761000.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620761000.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.418466.9", 
          "name": [
            "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Macharzina", 
        "givenName": "Roland", 
        "id": "sg:person.0772002125.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772002125.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.418466.9", 
          "name": [
            "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beschorner", 
        "givenName": "Ulrich", 
        "id": "sg:person.0642326255.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642326255.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.418466.9", 
          "name": [
            "Angiology Division, University Heart Center Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, D-79189, Bad Krozingen, Baden-W\u00fcrttemberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noory", 
        "givenName": "Elias", 
        "id": "sg:person.0610302262.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610302262.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00270-014-1024-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006096602", 
          "https://doi.org/10.1007/s00270-014-1024-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00270-008-9472-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029013758", 
          "https://doi.org/10.1007/s00270-008-9472-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-08-04", 
    "datePublishedReg": "2015-08-04", 
    "description": "Introducing anti-restenotic drug-based treatment modalities in femoropopliteal interventions is the potential revolutionizing reperfusion treatment of peripheral artery disease. Durability of recanalization procedures using drug-coated balloons (DCB) and drug-eluting stents (DES) yields in excellent mid-term and long-term technical and clinical outcomes and may be cost saving on the long term as compared to traditional treatment modalities such as plain old balloon angioplasty (POBA) and bare metal nitinol stent implantation. Drug-eluting bioresorbable scaffolds are another drug-based promising treatment option but are still investigational. In particular, DCB provide a novel method to locally deliver paclitaxel into the arterial wall without the need of a chronically implanted delivery system or even if those devices will be indicated, they can be delivered focally. Following the first positive pilot studies, two large pivotal trials have confirmed superiority of DCB over plain old balloon angioplasty (POBA) in the treatment of TASC II A and B femoropopliteal lesions. Even for more complex femoropopliteal lesions such as long lesions and instent restenosis, single center studies and small randomized studies have shown promising mid-term technical and clinical results. For DES, follow-up data for the only commercially available device are now presented up to 5\u00a0years with excellent clinical outcome regarding freedom from target lesion revascularization and improvement of walking capacity. This review article summarizes the current knowledge and perspectives of drug-based endovascular treatment modalities in femoropopliteal interventions and discusses still unresolved needs.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11886-015-0624-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021175", 
        "issn": [
          "1523-3782", 
          "1534-3170"
        ], 
        "name": "Current Cardiology Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "keywords": [
      "plain old balloon angioplasty", 
      "drug-coated balloons", 
      "peripheral artery disease", 
      "treatment modalities", 
      "artery disease", 
      "femoropopliteal lesions", 
      "clinical outcomes", 
      "femoropopliteal interventions", 
      "balloon angioplasty", 
      "superiority of DCB", 
      "advanced peripheral artery disease", 
      "nitinol stent implantation", 
      "large pivotal trials", 
      "TASC II A", 
      "target lesion revascularization", 
      "single-center study", 
      "excellent clinical outcomes", 
      "endovascular treatment modalities", 
      "complex femoropopliteal lesions", 
      "Drug-Coated Balloons", 
      "promising treatment option", 
      "traditional treatment modalities", 
      "bioresorbable scaffolds", 
      "drug eluting stents", 
      "reperfusion treatment", 
      "lesion revascularization", 
      "pivotal trials", 
      "center study", 
      "recanalization procedures", 
      "stent implantation", 
      "treatment options", 
      "clinical results", 
      "long lesions", 
      "instent restenosis", 
      "arterial wall", 
      "pilot study", 
      "lesions", 
      "angioplasty", 
      "modalities", 
      "disease", 
      "current knowledge", 
      "intervention", 
      "outcomes", 
      "review article", 
      "treatment", 
      "balloon", 
      "delivery system", 
      "long term", 
      "revascularization", 
      "cost savings", 
      "restenosis", 
      "stents", 
      "paclitaxel", 
      "trials", 
      "available devices", 
      "study", 
      "implantation", 
      "unresolved needs", 
      "options", 
      "years", 
      "need", 
      "management", 
      "DES", 
      "procedure", 
      "improvement", 
      "novel approach", 
      "wall", 
      "data", 
      "knowledge", 
      "scaffolds", 
      "results", 
      "capacity", 
      "perspective", 
      "superiority", 
      "article", 
      "method", 
      "devices", 
      "approach", 
      "novel method", 
      "system", 
      "terms", 
      "savings", 
      "durability", 
      "discusses", 
      "freedom", 
      "yield"
    ], 
    "name": "Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds", 
    "pagination": "69", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016374178"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11886-015-0624-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26238739"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11886-015-0624-6", 
      "https://app.dimensions.ai/details/publication/pub.1016374178"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_671.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11886-015-0624-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11886-015-0624-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11886-015-0624-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11886-015-0624-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11886-015-0624-6'


 

This table displays all metadata directly associated to this object as RDF triples.

228 TRIPLES      22 PREDICATES      124 URIs      114 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11886-015-0624-6 schema:about N2b2f9bccced04de0899aa92fee469b0f
2 N463b1ebb8b364042a4c5f29de880c828
3 N5940ccfc5f1746f18bd9053cbc58a2f3
4 N61001646fb6f446b9a08b891a22d882b
5 Nb6a55e872e034a74a2768404617441e4
6 Nb98bc9e83ffa434297020dc9207b2303
7 Nc89c3a64623d480cb5e87b54b41fed22
8 Ncdc29200edfc4db5be28834b4861c466
9 Nda79250487f24ad7ac29d11abe94d68a
10 Ne62a3c25f8ae4e3f95504a119b2504fb
11 Nec66f31bcc50454b9a2e61374a15a8bd
12 anzsrc-for:11
13 anzsrc-for:1115
14 schema:author N0e69e10fc7ca40b9b4de0d22f2b1a846
15 schema:citation sg:pub.10.1007/s00270-008-9472-8
16 sg:pub.10.1007/s00270-014-1024-9
17 schema:datePublished 2015-08-04
18 schema:datePublishedReg 2015-08-04
19 schema:description Introducing anti-restenotic drug-based treatment modalities in femoropopliteal interventions is the potential revolutionizing reperfusion treatment of peripheral artery disease. Durability of recanalization procedures using drug-coated balloons (DCB) and drug-eluting stents (DES) yields in excellent mid-term and long-term technical and clinical outcomes and may be cost saving on the long term as compared to traditional treatment modalities such as plain old balloon angioplasty (POBA) and bare metal nitinol stent implantation. Drug-eluting bioresorbable scaffolds are another drug-based promising treatment option but are still investigational. In particular, DCB provide a novel method to locally deliver paclitaxel into the arterial wall without the need of a chronically implanted delivery system or even if those devices will be indicated, they can be delivered focally. Following the first positive pilot studies, two large pivotal trials have confirmed superiority of DCB over plain old balloon angioplasty (POBA) in the treatment of TASC II A and B femoropopliteal lesions. Even for more complex femoropopliteal lesions such as long lesions and instent restenosis, single center studies and small randomized studies have shown promising mid-term technical and clinical results. For DES, follow-up data for the only commercially available device are now presented up to 5 years with excellent clinical outcome regarding freedom from target lesion revascularization and improvement of walking capacity. This review article summarizes the current knowledge and perspectives of drug-based endovascular treatment modalities in femoropopliteal interventions and discusses still unresolved needs.
20 schema:genre article
21 schema:inLanguage en
22 schema:isAccessibleForFree false
23 schema:isPartOf N1a687d9fdf00451b81e99718532d92b8
24 N381e2d221cbf4d9d95c0ff34589ba581
25 sg:journal.1021175
26 schema:keywords DES
27 Drug-Coated Balloons
28 TASC II A
29 advanced peripheral artery disease
30 angioplasty
31 approach
32 arterial wall
33 artery disease
34 article
35 available devices
36 balloon
37 balloon angioplasty
38 bioresorbable scaffolds
39 capacity
40 center study
41 clinical outcomes
42 clinical results
43 complex femoropopliteal lesions
44 cost savings
45 current knowledge
46 data
47 delivery system
48 devices
49 discusses
50 disease
51 drug eluting stents
52 drug-coated balloons
53 durability
54 endovascular treatment modalities
55 excellent clinical outcomes
56 femoropopliteal interventions
57 femoropopliteal lesions
58 freedom
59 implantation
60 improvement
61 instent restenosis
62 intervention
63 knowledge
64 large pivotal trials
65 lesion revascularization
66 lesions
67 long lesions
68 long term
69 management
70 method
71 modalities
72 need
73 nitinol stent implantation
74 novel approach
75 novel method
76 options
77 outcomes
78 paclitaxel
79 peripheral artery disease
80 perspective
81 pilot study
82 pivotal trials
83 plain old balloon angioplasty
84 procedure
85 promising treatment option
86 recanalization procedures
87 reperfusion treatment
88 restenosis
89 results
90 revascularization
91 review article
92 savings
93 scaffolds
94 single-center study
95 stent implantation
96 stents
97 study
98 superiority
99 superiority of DCB
100 system
101 target lesion revascularization
102 terms
103 traditional treatment modalities
104 treatment
105 treatment modalities
106 treatment options
107 trials
108 unresolved needs
109 wall
110 years
111 yield
112 schema:name Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds
113 schema:pagination 69
114 schema:productId N48547762c23e468287ab3e22b496a3ae
115 Na110ad2237dd4110a37a84c11ff77d47
116 Ne7b0013c828f451a865268ef4e94d37a
117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016374178
118 https://doi.org/10.1007/s11886-015-0624-6
119 schema:sdDatePublished 2022-05-10T10:11
120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
121 schema:sdPublisher N56e6a44f97fc4ccfa234bb2a4b6d0c66
122 schema:url https://doi.org/10.1007/s11886-015-0624-6
123 sgo:license sg:explorer/license/
124 sgo:sdDataset articles
125 rdf:type schema:ScholarlyArticle
126 N0e69e10fc7ca40b9b4de0d22f2b1a846 rdf:first sg:person.01306206724.74
127 rdf:rest N5a2e4f17d3784691811f9677a0992363
128 N1a687d9fdf00451b81e99718532d92b8 schema:issueNumber 9
129 rdf:type schema:PublicationIssue
130 N2b2f9bccced04de0899aa92fee469b0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Femoral Artery
132 rdf:type schema:DefinedTerm
133 N381e2d221cbf4d9d95c0ff34589ba581 schema:volumeNumber 17
134 rdf:type schema:PublicationVolume
135 N463b1ebb8b364042a4c5f29de880c828 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cardiovascular Agents
137 rdf:type schema:DefinedTerm
138 N48547762c23e468287ab3e22b496a3ae schema:name dimensions_id
139 schema:value pub.1016374178
140 rdf:type schema:PropertyValue
141 N56e6a44f97fc4ccfa234bb2a4b6d0c66 schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 N5940ccfc5f1746f18bd9053cbc58a2f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Vascular Patency
145 rdf:type schema:DefinedTerm
146 N5a2e4f17d3784691811f9677a0992363 rdf:first sg:person.0620761000.30
147 rdf:rest N944a177740c24cc591dd5c6b03847dc7
148 N61001646fb6f446b9a08b891a22d882b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Absorbable Implants
150 rdf:type schema:DefinedTerm
151 N68a0a30201514fe79bdf1a32babdd9dd rdf:first sg:person.0610302262.30
152 rdf:rest rdf:nil
153 N944a177740c24cc591dd5c6b03847dc7 rdf:first sg:person.0772002125.83
154 rdf:rest Nc5ee477b261e420db9a958c615e6eb07
155 Na110ad2237dd4110a37a84c11ff77d47 schema:name doi
156 schema:value 10.1007/s11886-015-0624-6
157 rdf:type schema:PropertyValue
158 Nb6a55e872e034a74a2768404617441e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Coated Materials, Biocompatible
160 rdf:type schema:DefinedTerm
161 Nb98bc9e83ffa434297020dc9207b2303 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Peripheral Arterial Disease
163 rdf:type schema:DefinedTerm
164 Nc5ee477b261e420db9a958c615e6eb07 rdf:first sg:person.0642326255.24
165 rdf:rest N68a0a30201514fe79bdf1a32babdd9dd
166 Nc89c3a64623d480cb5e87b54b41fed22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Popliteal Artery
168 rdf:type schema:DefinedTerm
169 Ncdc29200edfc4db5be28834b4861c466 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Drug-Eluting Stents
171 rdf:type schema:DefinedTerm
172 Nda79250487f24ad7ac29d11abe94d68a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Angioplasty, Balloon
174 rdf:type schema:DefinedTerm
175 Ne62a3c25f8ae4e3f95504a119b2504fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Blood Flow Velocity
177 rdf:type schema:DefinedTerm
178 Ne7b0013c828f451a865268ef4e94d37a schema:name pubmed_id
179 schema:value 26238739
180 rdf:type schema:PropertyValue
181 Nec66f31bcc50454b9a2e61374a15a8bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Humans
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
188 schema:name Pharmacology and Pharmaceutical Sciences
189 rdf:type schema:DefinedTerm
190 sg:journal.1021175 schema:issn 1523-3782
191 1534-3170
192 schema:name Current Cardiology Reports
193 schema:publisher Springer Nature
194 rdf:type schema:Periodical
195 sg:person.01306206724.74 schema:affiliation grid-institutes:grid.418466.9
196 schema:familyName Zeller
197 schema:givenName Thomas
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74
199 rdf:type schema:Person
200 sg:person.0610302262.30 schema:affiliation grid-institutes:grid.418466.9
201 schema:familyName Noory
202 schema:givenName Elias
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610302262.30
204 rdf:type schema:Person
205 sg:person.0620761000.30 schema:affiliation grid-institutes:grid.418466.9
206 schema:familyName Rastan
207 schema:givenName Aljoscha
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620761000.30
209 rdf:type schema:Person
210 sg:person.0642326255.24 schema:affiliation grid-institutes:grid.418466.9
211 schema:familyName Beschorner
212 schema:givenName Ulrich
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642326255.24
214 rdf:type schema:Person
215 sg:person.0772002125.83 schema:affiliation grid-institutes:grid.418466.9
216 schema:familyName Macharzina
217 schema:givenName Roland
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772002125.83
219 rdf:type schema:Person
220 sg:pub.10.1007/s00270-008-9472-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029013758
221 https://doi.org/10.1007/s00270-008-9472-8
222 rdf:type schema:CreativeWork
223 sg:pub.10.1007/s00270-014-1024-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006096602
224 https://doi.org/10.1007/s00270-014-1024-9
225 rdf:type schema:CreativeWork
226 grid-institutes:grid.418466.9 schema:alternateName Angiology Division, University Heart Center Freiburg – Bad Krozingen, Südring 15, D-79189, Bad Krozingen, Baden-Württemberg, Germany
227 schema:name Angiology Division, University Heart Center Freiburg – Bad Krozingen, Südring 15, D-79189, Bad Krozingen, Baden-Württemberg, Germany
228 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...